DERIVATIVES |
3 Months Ended |
|---|---|
Mar. 31, 2026 | |
| Derivatives [Abstract] | |
| Derivatives |
NOTE 5 – DERIVATIVES
The Company enters into derivative financial instruments to manage exposures
receipt or payment of future known and uncertain cash amounts, the value of
derivative financial instruments are used to manage differences in
expected cash receipts and its known or expected cash payments principally
Cash Flow Hedges of Interest Rate Risk
The Company previously maintained interest rate swaps with notional amounts
30
for subordinated debt. Under the swap arrangement, the Company paid
2.50
% and received a variable interest
rate based on three-month CME Term
assets. The unrealized gain of $
2.7
straight-line basis into interest expense through the remaining term of the
be approximately $
0.8
For derivatives designated and that qualify as cash flow hedges of interest rate
accumulated other comprehensive income (“AOCI”) and subsequently
which the hedged transaction affects earnings. Amounts reported
as interest payments are made on the Company’s
The following table presents the change in net gains (losses) recorded in AOCI and
the cash flow derivative instruments (interest rate swaps related to subordinated
Change in Gain
Amount of Gain
(Loss) Recognized
(Loss) Reclassified
(Dollars in Thousands)
Category
in AOCI
from AOCI to Income
Three months ended March 31, 2026
Interest expense
$
-
$
198
Three months ended March 31, 2025
Interest expense
326
375
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The entire disclosure for derivative instruments and hedging activities including, but not limited to, risk management strategies, non-hedging derivative instruments, assets, liabilities, revenue and expenses, and methodologies and assumptions used in determining the amounts. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|